ALK and non-small cell lung carcinoma: For the control group, we screened 1377 consecutive NSCLC patients in SYSUCC from 10th Jan 2012 to 25th Apr 2014, 194 advanced both ALK‐ and EGFR‐negative patients were enrolled.